Epigenetics PARP Inhibitors Chemotherapy DNA Serine-Threonine Kinase Inhibitors Tyrosine Kinase Inhibitors Immunotherapy CD Protein Inhibitors Immune Checkpoint Inhibitors Other | Mesothelioma | Cholangiocarcinoma | Melanoma | Clear Cell Renal Cell Carcinoma | Malignant Pleural Mesothelioma | Urothelial Cancer | Renal Cell Carcinoma | Solid Tumor | Uveal Melanoma |
---|---|---|---|---|---|---|---|---|---|
tazemetostat | |||||||||
olaparib | |||||||||
vorinostat | |||||||||
rucaparib | |||||||||
FF-10502 | |||||||||
niraparib + dostarlimab-gxly | |||||||||
cisplatin + gemcitabine | |||||||||
everolimus | |||||||||
JNJ 26481585 | |||||||||
Tyrosine kinase inhibitor | |||||||||
BET inhibitor | |||||||||
Immunotherapy | |||||||||
Glutamate inhibitor |